NSETrading Window30 Sept 2026 · 30 Sept 2026, 05:34 pm
Trading Window
Natco Pharma Limited · NATCOPHARM
✦ AI Summary
Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from October 1, 2026 to 48 hours after the declaration of the Unaudited Financial Results for the quarter ending September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
NATCOPHARM_30092026173434_Trading_Window_ClosureSE_Intimation.pdf
View document text
30th September, 2026
M/s. BSE Limited M/s. National Stock Exchange of India Ltd
Mumbai 400 001 Mumbai 400 051
Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir/Madam,
Sub:- Closure of Trading Window
We wish to inform you that the Trading Window for dealing in the securities of the Company
would remain closed for the Directors, Designated Persons, their immediate relatives and all
other connected persons covered in terms of the Code of Conduct of the Company under the
SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, with
effect from October 1, 2026 to till 48 hours after the declaration of the Unaudited Financial
Results of the Company for the quarter ending September 30, 2026.
The date of the Board Meeting for declaration of the unaudited financial results of the
Company for the quarter ending September 30, 2026 will be intimated in due course of time.
Thanking you
Yours faithfully
For NATCO Pharma Limited
Ch. Venkat Ramesh
Company Secretary &
Compliance Officer